Exoluma™ by Genèse Labs France Launched and Added to EG Bio’s Global Portfolio

Dual-type exosome solutions strengthen regenerative aesthetic offerings

In November 2024, Exoluma™, an advanced exosome-based aesthetic product line developed by Genèse Labs France, was officially launched and added to EG Bio Co., Ltd.’s global distribution portfolio.

Exoluma™ represents the next generation of regenerative aesthetic solutions, designed to support skin rejuvenation and cellular renewal. The line includes two distinct formulations, each developed to meet specific clinical and market needs:

• Exoluma™ Human: A human-derived exosome solution developed for applications where human cell–based regenerative support is preferred, aligning with professional aesthetic treatment approaches.

• Exoluma™ Plant: A plant-derived exosome alternative, offering a plant-based regenerative option that addresses market segments and regulatory environments where plant-origin products are advantageous.

Both formulations are developed with a focus on quality, stability, and compatibility with international professional aesthetic standards.

Why the Launch of Exoluma™ Is Significant

The addition of Exoluma™ to EG Bio’s distribution portfolio reinforces the company’s regenerative category and supports its vision of offering diversified, high-quality aesthetic solutions to global partners. By presenting dual-type exosome products, the collaboration enables distributors and professional partners to select solutions that best fit their regional regulatory context and clinical positioning.

This launch reflects the ongoing cooperation between Genèse Labs France and EG Bio, combining innovative product development with structured global distribution capabilities.

About Genèse Labs France

Genèse Labs France is a France-based aesthetic company focused on the development and management of professional aesthetic and dermocosmetic product portfolios. With emphasis on regulatory alignment and international quality standards, Genèse Labs France works with selected manufacturing and distribution partners to support structured global market expansion and long-term brand positioning.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company collaborates with internationally positioned brands and manufacturers to support structured global distribution, portfolio development, and long-term partnerships across multiple regions.